| NCT03409549 |
Multi-parametric MRI/Fluorine-18 Fluciclovine PET-CT in Glioblastoma |
https://ClinicalTrials.gov/show/NCT03409549 |
Recruiting |
The Leeds Teaching Hospitals NHS Trust |
2020-10-31 |
| NCT03294434 |
Predicting Sites of Tumour Progression in the Invasive Margin of Glioblastomas (PRaM-GBM Study) |
https://ClinicalTrials.gov/show/NCT03294434 |
Recruiting |
Cambridge University Hospitals NHS Foundation Trust |
2020-12-30 |
| NCT03258021 |
TTFields In GErmany in Routine Clinical Care |
https://ClinicalTrials.gov/show/NCT03258021 |
Recruiting |
NovoCure Ltd. |
2021-02-28 |
| NCT03194971 |
NovoTTF Treatment Signatures in Glioblastoma Patients at Autopsy |
https://ClinicalTrials.gov/show/NCT03194971 |
Recruiting |
Medical College of Wisconsin |
2021-05-31 |
| NCT03005132 |
Integrative Analysis of Human Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT03005132 |
Recruiting |
Shanghai 10th People’s Hospital |
2026-12-31 |
| NCT02997423 |
Cytochrome C Oxidase Activity in Newly Diagnosed Glioblastoma Multiforme (GBM) |
https://ClinicalTrials.gov/show/NCT02997423 |
Active, not recruiting |
University of Iowa |
2020-11-30 |
| NCT02899663 |
MRI Detection of Microbleeds in Glioma Patients |
https://ClinicalTrials.gov/show/NCT02899663 |
Completed |
Fondation Ophtalmologique Adolphe de Rothschild |
2015-08-31 |
| NCT02887417 |
Glioblastoma Platelet Activation Study |
https://ClinicalTrials.gov/show/NCT02887417 |
Completed |
University Medicine Greifswald |
2016-10-31 |
| NCT02843230 |
Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI |
https://ClinicalTrials.gov/show/NCT02843230 |
Recruiting |
Massachusetts General Hospital |
2019-08-31 |
| NCT02725684 |
Using Genomic Analysis to Guide Individual Treatment in Glioblastoma |
https://ClinicalTrials.gov/show/NCT02725684 |
Completed |
Rockefeller University |
2017-07-07 |
| NCT02666066 |
Radiomics for Prediction of Survival in GBM |
https://ClinicalTrials.gov/show/NCT02666066 |
Completed |
Maastricht Radiation Oncology |
2018-01-31 |
| NCT00083512 |
Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT00083512 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT02520635 |
Supra-early Post-Surgery Chemotherapy in the Treatment on GBM Patients |
https://ClinicalTrials.gov/show/NCT02520635 |
Recruiting |
Beijing Tiantan Hospital |
2020-12-31 |
| NCT02473484 |
Search of Protein Biomarkers in Order to Achieve a Molecular Classification of Gliomas |
https://ClinicalTrials.gov/show/NCT02473484 |
Completed |
University Hospital, Lille |
2017-10-31 |
| NCT02458508 |
Retrospective Evaluation of Melanocortin Receptor 4 Polymorphisms in Patients With GBM Treated With Radiochemotherapy |
https://ClinicalTrials.gov/show/NCT02458508 |
Completed |
University of Pisa |
2016-12-31 |
| NCT02375841 |
Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers |
https://ClinicalTrials.gov/show/NCT02375841 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2021-02-28 |
| NCT02367482 |
Tryptophan Metabolism in Human Brain Tumors |
https://ClinicalTrials.gov/show/NCT02367482 |
Recruiting |
Wayne State University |
2020-12-31 |
| NCT02060890 |
Molecular Profiling in Guiding Individualized Treatment Plan in Adults With Recurrent/Progressive Glioblastoma |
https://ClinicalTrials.gov/show/NCT02060890 |
Completed |
University of California, San Francisco |
2015-09-03 |
| NCT02006563 |
Metabolic Tumor Volumes in Radiation Treatment of Primary Brain Tumors |
https://ClinicalTrials.gov/show/NCT02006563 |
Completed |
University of Miami |
2016-01-31 |
| NCT01880008 |
Evaluation of FLT PET and MRI as Imaging Biomarkers of Early Treatment Response in Patients With Glioblastoma |
https://ClinicalTrials.gov/show/NCT01880008 |
Completed |
Washington University School of Medicine |
2010-02-28 |
| NCT01873469 |
Impact of [11C]-Methionine PET/MRI for Individual Tailoring Postoperative Radiochemotherapy for Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT01873469 |
Completed |
Technische Universität Dresden |
2017-10-31 |
| NCT01849952 |
Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas |
https://ClinicalTrials.gov/show/NCT01849952 |
Recruiting |
Dartmouth-Hitchcock Medical Center |
2022-05-31 |
| NCT01712542 |
Curcumin Bioavailability in Glioblastoma Patients |
https://ClinicalTrials.gov/show/NCT01712542 |
Completed |
Johann Wolfgang Goethe University Hospital |
2013-05-31 |
| NCT01618747 |
An Observational Study of Avastin (Bevacizumab) in Patients With Glioblastoma Multiforme in First or Second Relapse |
https://ClinicalTrials.gov/show/NCT01618747 |
Completed |
Hoffmann-La Roche |
2015-12-24 |
| NCT01604590 |
Imaging Biomarkers of Tissue Microstructure and Vasculature as Predictors of Glioblastoma Multiforme |
https://ClinicalTrials.gov/show/NCT01604590 |
Completed |
Medical University of South Carolina |
2014-06-30 |
| NCT01598597 |
An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite) |
https://ClinicalTrials.gov/show/NCT01598597 |
Completed |
Genentech, Inc. |
2014-11-30 |
| NCT01516905 |
PET/CT Imaging of Malignant Brain Tumors With 124I-NM404 |
https://ClinicalTrials.gov/show/NCT01516905 |
Completed |
University of Wisconsin, Madison |
2016-05-17 |
| NCT01493219 |
Biomarkers for Prognosis of Glioblastoma (GBM) |
https://ClinicalTrials.gov/show/NCT01493219 |
Completed |
University of Nebraska |
2017-09-30 |
| NCT01345370 |
Comparison of Different Methods to Test MGMT Status in Glioblastoma Patients |
https://ClinicalTrials.gov/show/NCT01345370 |
Completed |
Center Eugene Marquis |
2015-04-30 |
| NCT04359745 |
Improving Treatment of Glioblastoma: Distinguishing Progression From Pseudoprogression |
https://ClinicalTrials.gov/show/NCT04359745 |
Recruiting |
Guy’s and St Thomas’ NHS Foundation Trust |
2023-05-26 |
| NCT04313842 |
A Explorative Study to Evaluate the Clinical Feasibility of AVATAMED |
https://ClinicalTrials.gov/show/NCT04313842 |
Recruiting |
Samsung Medical Center |
2021-06-01 |
| NCT04171895 |
Communication Training for Caregivers In Advanced Care Planning |
https://ClinicalTrials.gov/show/NCT04171895 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2021-10-31 |
| NCT04180046 |
Utility of Primary Glioblastoma Cell Lines |
https://ClinicalTrials.gov/show/NCT04180046 |
Active, not recruiting |
Neuromed IRCCS |
2019-06-26 |
| NCT04143425 |
Response Prediction for Anti-angiogenic Treatment in Recurrent Glioblastoma |
https://ClinicalTrials.gov/show/NCT04143425 |
Recruiting |
Asan Medical Center |
2022-06-30 |
| NCT03939858 |
Bioenergetic Profiling and Cognition in GBM Patients |
https://ClinicalTrials.gov/show/NCT03939858 |
Recruiting |
Wake Forest University Health Sciences |
2020-08-31 |
| NCT03900689 |
Social Determinants of Health in Glioblastoma Population |
https://ClinicalTrials.gov/show/NCT03900689 |
Recruiting |
Wake Forest University Health Sciences |
2021-05-31 |
| NCT03877861 |
Validation of Readibandâ„¢ Actigraph and Associated Sleep/Wake Classification Algorithms |
https://ClinicalTrials.gov/show/NCT03877861 |
Recruiting |
Allina Health System |
2020-12-31 |
| NCT03865355 |
Blood and Cerebrospinal Fluid Metabolomic Profile in Glioma Patients |
https://ClinicalTrials.gov/show/NCT03865355 |
Recruiting |
Novosibirsk State University |
2024-04-11 |
| NCT03770468 |
Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma |
https://ClinicalTrials.gov/show/NCT03770468 |
Recruiting |
European Organisation for Research and Treatment of Cancer - EORTC |
2021-12-31 |
| NCT03687099 |
Immunological and Functional Characterization of Cellular Population CD45+ Infiltrating Human Glioblastoma |
https://ClinicalTrials.gov/show/NCT03687099 |
Recruiting |
Centre Hospitalier Universitaire, Amiens |
2019-07-30 |
| NCT03623347 |
Upfront Bevacizumab/témozolomide for Gliomastomas With Neurological Impairment |
https://ClinicalTrials.gov/show/NCT03623347 |
Completed |
Centre Hospitalier Universitaire, Amiens |
2017-05-12 |
| NCT03593993 |
A Biospecimen Collection Study in BRAF-V600E Mutated Recurrent Gliomas |
https://ClinicalTrials.gov/show/NCT03593993 |
Recruiting |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2021-05-19 |
| NCT03567135 |
Temozolomide Plus Anti-angiogenesis Drugs and Radiotherapy as a Treatment for Glioblastoma |
https://ClinicalTrials.gov/show/NCT03567135 |
Recruiting |
Fuzhou General Hospital |
2019-04-01 |
| NCT03439332 |
Multicentre Validation of How Vascular Biomarkers From Tumor Can Predict the Survival of the Patient With Glioblastoma |
https://ClinicalTrials.gov/show/NCT03439332 |
Completed |
Universitat Politècnica de València |
2018-07-01 |
| NCT02022384 |
Immunophenotyping From Blood of Patients With Malignant Gliomas |
https://ClinicalTrials.gov/show/NCT02022384 |
Recruiting |
University of Erlangen-Nürnberg Medical School |
2020-12-31 |
| NCT01135875 |
Laboratory Study of Early Tumor Markers in the Peripheral Blood of Glioblastoma Multiforme Patients |
https://ClinicalTrials.gov/show/NCT01135875 |
Completed |
University of Florida |
2013-04-30 |
| NCT01124461 |
BIRN (Biomedical Informatics Research Network) Resources Facilitate the Personalization of Malignant Brain Tumor |
https://ClinicalTrials.gov/show/NCT01124461 |
Completed |
Washington University School of Medicine |
2017-11-30 |
| NCT01089868 |
Usefulness of Therapy Monitoring by Means of [(18)F]Fluoroethyltyrosine-Positron Emission Tomography (FET-PET) in Glioblastoma Multiforme Patients |
https://ClinicalTrials.gov/show/NCT01089868 |
Completed |
Ludwig-Maximilians - University of Munich |
2011-06-30 |
| NCT00973557 |
The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary Function |
https://ClinicalTrials.gov/show/NCT00973557 |
Completed |
Cedars-Sinai Medical Center |
2011-09-30 |
| NCT00897663 |
Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies |
https://ClinicalTrials.gov/show/NCT00897663 |
Completed |
Alliance for Clinical Trials in Oncology |
2018-01-31 |
| NCT03896958 |
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) |
https://ClinicalTrials.gov/show/NCT03896958 |
Recruiting |
SpeciCare |
2021-03-12 |
| NCT02905643 |
Discerning Pseudoprogression vs True Tumor Growth in GBMs |
https://ClinicalTrials.gov/show/NCT02905643 |
Completed |
Ascension St. Vincent |
2018-02-13 |
| NCT00777686 |
Measuring Non-Enhancing Glioblastoma Progression |
https://ClinicalTrials.gov/show/NCT00777686 |
Completed |
M.D. Anderson Cancer Center |
2011-03-31 |
| NCT00723827 |
Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2) |
https://ClinicalTrials.gov/show/NCT00723827 |
Completed |
Merck Sharp & Dohme Corp. |
2011-09-30 |
| NCT00725010 |
Temozolomide in Concomitant Radiochemotherapy Followed by Sequential Temozolomide Chemotherapy - Observational Program (Study P04816) |
https://ClinicalTrials.gov/show/NCT00725010 |
Completed |
Merck Sharp & Dohme Corp. |
2009-04-30 |
| NCT00704808 |
Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739) |
https://ClinicalTrials.gov/show/NCT00704808 |
Completed |
Merck Sharp & Dohme Corp. |
2008-12-31 |
| NCT00001171 |
Evaluation of Factors in Human Brain Tumors |
https://ClinicalTrials.gov/show/NCT00001171 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00009035 |
Natural History of Patients With Brain and Spinal Cord Tumors |
https://ClinicalTrials.gov/show/NCT00009035 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001148 |
Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor |
https://ClinicalTrials.gov/show/NCT00001148 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |